Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
The ethical basis for entering patients in randomised
controlled trials is under debate. Some doctors espouse the uncertainty principle whereby randomisation to treatment is acceptable when an
individual doctor is genuinely unsure which treatment is best for a
patient. Others believe that clinical equipoise, reflecting collective
professional uncertainty over treatment, is the soundest ethical
criterion. Here doctors from two Canadian centres discuss their positions.
Charles Weijer a Department of Bioethics, Dalhousie
University, Halifax, NS B3H 4H7, Canada, b Department of
Epidemiology and Biostatistics, McGill University, Montreal H3A 1A2,
Canada, c Biomedical Ethics Unit, Department of Human Genetics and
Department of Pediatrics, McGill University
Correspondence to: C
Weijer charles.weijer@dal.ca
On what ethical grounds may a physician offer trial
participation to his or her patient? The answer seems to depend
greatly on which side of the Atlantic you reside. In the United
Kingdom, the uncertainty principle is widely
endorsed.
1 2
However, in North America, clinical
equipoise It is widely acknowledged that physicians have a primary duty to
promote their patients' welfare. When physicians become investigators,
reflecting collective uncertainty
is the dominant ethical
basis.3 Which of these principles offers the preferred
moral underpinning for the randomised controlled trial?
Read all Rapid Responses